Complete response of severe symptomatic bone marrow metastases from heavily pretreated breast cancer with a 3-weekly trastuzumab schedule. A clinical case.

Source:http://linkedlifedata.com/resource/pubmed/id/15015614

Download in:

View as

General Info

PMID
15015614